An Tiến Industries (HII): cyclical chemical player; valuation slightly above our isotonic-calibrated mid-cycle EV/EBITDA
Intrinsic value VND 8,239 vs market VND 8,600, implied downside -4.2% (confidence: very_low).
Business Overview
Công ty Cổ phần An Tiến Industries (HII) is listed on HOSE in the cyclical chemicals sector (ICB: Hóa chất). The company operates in downstream chemical/packaging-related activities typical of Vietnam's domestic industrial supply chain (industry details are sector-level; company-level segment breakdown is limited in the input). It is a mid-cap issuer with 73,663,016 shares outstanding and a concentrated ownership structure: the largest shareholder, Công ty Cổ phần Nhựa An Phát Xanh, holds 45.1% of shares.
Investment Thesis
HII's valuation and operating profile point to limited near-term upside but persistent execution and cyclical risks. Key facts: the model-implied intrinsic value is VND 8,239 vs the market at VND 8,600 (implied downside -4.2%) and the model confidence is very_low after isotonic calibration using seven years of data. Operating profitability is thin: ROE is 5.8% and ROA 2.7%, with an EBIT margin of 1.5% and net margin of 0.8%. Leverage is material (Debt/Equity ~1.0) which, combined with modest margins, increases sensitivity to demand slowdowns in a cyclical chemical market. Valuation on reported multiples is mixed: P/E ~12.5 and EV/EBITDA ~5.4 suggest some discount to sector EV/EBITDA (sector median 9.17), but the model uses a fair EV/EBITDA of 5.9 (own history) to derive the mid-cycle intrinsic value, and calibration raises uncertainty (raw intrinsic value before calibration was VND 6,600).
Valuation Commentary
Mid-cycle EV/EBITDA valuation calibrated isotonically to historical outcomes; we apply a fair EV/EBITDA multiple to a median/mid-cycle EBITDA and subtract net debt to derive intrinsic equity value per share.
- Mid-cycle EBITDA series used in the model with seven years of data and an EBITDA coefficient of variation of 0.7371 (model_inputs.years_of_data = 7; ebitda_cv = 0.7371).
- Model fair EV/EBITDA multiple = 5.9 (source: own_history) vs sector EV/EBITDA = 9.17.
- Calibration moved the raw intrinsic value (VND 6,600.2) up to the final intrinsic value VND 8,239 via isotonic recalibration.
- Model confidence labeled very_low after recalibration, reflecting limited predictive stability for this stock.
The implied downside of -4.2% is small but, given the model's very_low confidence and the high EBITDA variability input (ebitda_cv = 0.7371), the intrinsic estimate is highly uncertain. The difference between raw intrinsic value (VND 6,600.2) and calibrated outcome underscores model instability; treat the VND 8,239 as a low-confidence anchor rather than a precise fair price.
Bull vs Bear
- EV/EBITDA is modest at 5.4, below the sector EV/EBITDA of 9.17, leaving valuation scope if margins recover or multiples re-rate.
- P/B of 0.7 and P/E of 12.5 indicate the market currently prices a modest recovery scenario without premium multiple risk.
- Earnings quality score is high at 82.3, suggesting reported profits are reasonably reliable despite volatility.
- Low operating margins: gross margin 7.0% and EBIT margin 1.5% constrain free cash flow generation and make results sensitive to raw-material and volume swings.
- Leverage is material (Debt/Equity ~1.0), which increases downside if cyclical demand softens or input costs rise.
- Model confidence is very_low and isotonic calibration moved the raw intrinsic value (VND 6,600.2) to VND 8,239, indicating valuation instability and forecasting risk.
- Top shareholder concentration is high (45.1% held by Công ty Cổ phần Nhựa An Phát Xanh), which can limit free-float liquidity and subjects minority holders to strategic decisions by the parent/investor.
Sector Context
The chemicals sector in Vietnam is cyclical and exposed to global commodity swings as well as domestic industrial demand. The peer set shows dispersion: sector median modeled upside is 5.6% while top peers (e.g., CST, KVC, NBC) show >40% modeled upside in our universe, highlighting company-specific differences in margins, balance-sheet strength, and growth prospects. Regulatory and macro factors matter: import/export policy, RMB/commodity cycles, and Vietnam's manufacturing demand will drive near-term volumes. Inbanking/finance-adjacent context, banks and suppliers may use VAMC-like tools or credit quotas from SBV in stressed scenarios; chemical firms reliant on working capital lines face SBV quota and liquidity dynamics. Real-economy linkages and cyclical inventory build can amplify earnings volatility; peers at the bottom of the model universe show negative modeled returns, underscoring idiosyncratic execution risk across the sector.
Risk Factors
- Cyclical demand risk: Revenue YoY growth was 4.6% in the latest period, but chemicals are sensitive to industrial and export cycles.
- Thin margins: Net profit margin ~0.8% and EBIT margin ~1.5% leave little buffer for input-cost inflation or pricing pressure.
- Leverage: Debt/Equity ~1.0 increases financial risk and reduces flexibility if operating cash flow weakens.
- Valuation/model uncertainty: Model confidence is very_low and isotonic calibration materially changed the raw intrinsic value (raw_intrinsic_value = 6,600.2), signalling forecasting instability.
- Ownership concentration: a 45.1% block held by a single institutional shareholder limits free float and could influence capital allocation decisions (dividends, related-party transactions).
- Liquidity/foreign participation: although average 2-week volume is reasonable (avg_volume_2w = 722,144), foreign_room is finite (36,665,794.94257624) and may constrain demand from non-resident buyers.
Catalysts
- Margin recovery from cost normalization or successful price pass-through could lift EBITDA and improve EV/EBITDA multiples.
- Improved model confidence via stable EBITDA outcomes for multiple quarters (the model currently uses 7 years with ebitda_cv = 0.7371).
- Any change in ownership or a strategic move by the 45.1% shareholder that increases free float or signals capital allocation priorities (dividend/share buybacks).
Forensic Assessment
No Beneish M-Score is provided (mscore = null) and no forensic red flags are listed. Earnings quality is relatively strong at 82.3, which supports the integrity of reported profits. Given the lack of explicit forensic flags, the principal concerns are forecasting difficulty (high EBITDA variability) and ownership concentration rather than accounting manipulation.
Track Record
Model track record spans 10 years (first_year 2017 to last_year 2026) with a hit rate of 55.6% (hit_rate = 0.5556) and an average reported upside of 30.1% historically. The hit rate is modest — slightly better than coin-flip — so historical performance offers limited confidence. Combined with the current model confidence labeled very_low, past success should be treated cautiously when forming conviction.
Written by a language model on 2026-08-28 from this page’s own model outputs and financial statements, and may quote figures from that date. Descriptive analysis, not investment advice — no buy, sell or hold recommendation is given or implied.